Before Canadian Senate, Zivadinov Urges Caution for CCSVI Treatment

Before Canadian Senate, Zivadinov Urges Caution for CCSVI Treatment

Robert Zivadinov, MD, PhD, recently told the Canadian Senate that only patients in approved clinical trials should receive endovascular treatment for chronic cerobrospinal venous insufficiency.

Advertisements